These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21986824)

  • 21. Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters.
    Jacobs MR
    Clin Microbiol Infect; 2001 Nov; 7(11):589-96. PubMed ID: 11737083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline administered alone and in combination with carprofen in calves.
    Brentnall C; Cheng Z; McKellar QA; Lees P
    Res Vet Sci; 2013 Jun; 94(3):687-94. PubMed ID: 23415880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.
    Girard D; Finegan SM; Dunne MW; Lame ME
    J Antimicrob Chemother; 2005 Aug; 56(2):365-71. PubMed ID: 16002421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic-Pharmacodynamic Characterization of Omadacycline against Haemophilus influenzae Using a One-Compartment
    VanScoy BD; Lakota EA; Conde H; McCauley J; Friedrich L; Steenbergen JN; Ambrose PG; Bhavnani SM
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32284378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
    Peric M; Browne FA; Jacobs MR; Appelbaum PC
    Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model.
    Andes D; Marchillo K; Stamstad T; Conklin R
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3165-9. PubMed ID: 14506026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint.
    Drusano GL; Preston SL; Hardalo C; Hare R; Banfield C; Andes D; Vesga O; Craig WA
    Antimicrob Agents Chemother; 2001 Jan; 45(1):13-22. PubMed ID: 11120938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacodynamics of gemifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model of infection.
    MacGowan AP; Rogers CA; Holt HA; Wootton M; Bowker KE
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2916-21. PubMed ID: 11557490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics/pharmacodynamics of antofloxacin hydrochloride in a neutropenic murine thigh model of Staphylococcus aureus infection.
    Xiao XM; Xiao YH
    Acta Pharmacol Sin; 2008 Oct; 29(10):1253-60. PubMed ID: 18817632
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Zhou YF; Tao MT; He YZ; Sun J; Liu YH; Liao XP
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection models.
    Andes D; Craig WA
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1665-70. PubMed ID: 12019073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo pharmacokinetic/pharmacodynamic activity of clofoctol.
    Scaglione F; Dugnani S; Lucini V; Pannacci M; Paraboni L
    J Chemother; 2012 Aug; 24(4):201-6. PubMed ID: 23040683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model.
    Chan E; Zhou S; Srikumar S; Duan W
    Pharm Res; 2006 Apr; 23(4):729-41. PubMed ID: 16554956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacodynamics: relation to antimicrobial resistance.
    Rybak MJ
    Am J Med; 2006 Jun; 119(6 Suppl 1):S37-44; discussion S62-70. PubMed ID: 16735150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis.
    Andes D; Marchillo K; Conklin R; Krishna G; Ezzet F; Cacciapuoti A; Loebenberg D
    Antimicrob Agents Chemother; 2004 Jan; 48(1):137-42. PubMed ID: 14693531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an In Vitro Infection Model.
    VanScoy BD; McCauley J; Ellis-Grosse EJ; Okusanya OO; Bhavnani SM; Forrest A; Ambrose PG
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7170-7. PubMed ID: 26100706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models.
    Dudhani RV; Turnidge JD; Coulthard K; Milne RW; Rayner CR; Li J; Nation RL
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1117-24. PubMed ID: 20028824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh model.
    Hegde SS; Okusanya OO; Skinner R; Shaw JP; Obedencio G; Ambrose PG; Blais J; Bhavnani SM
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1578-83. PubMed ID: 22155835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets.
    Zhou YF; Bu MX; Liu P; Sun J; Liu YH; Liao XP
    BMC Vet Res; 2020 Mar; 16(1):81. PubMed ID: 32138735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic-pharmacodynamic integration and modelling of florfenicol in calves.
    Sidhu P; Rassouli A; Illambas J; Potter T; Pelligand L; Rycroft A; Lees P
    J Vet Pharmacol Ther; 2014 Jun; 37(3):231-42. PubMed ID: 24341543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.